FACULTY

Michael E. Wechsler, MD, MMSc
Professor of Medicine, National Jewish Health
Director, NJH Cohen Family Asthma Institute
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, Colorado

PROGRAM OVERVIEW

This enduring activity is designed to enhance healthcare professionals’ understanding of the role of type 2 inflammation in asthma’s complex pathology and its impact on disease progression. Participants will explore evidence-based approaches for incorporating biologic therapies into individualized treatment plans and learn strategies for selecting the most appropriate biologic therapy based on patient-specific needs, preferences, and goals to optimize outcomes in moderate-to-severe asthma management. The program will also review GINA recommendations and when to incorporate biologic therapy.

TARGET AUDIENCE

This activity is designed to meet the educational needs of US-based community-based practitioners, pulmonologists, respiratory technicians, respiratory therapists, and other healthcare providers involved in the care of patients with moderate-to-severe asthma.

LEARNING OBJECTIVES

• Explain the role of type 2 inflammation in the complex pathology of asthma
• Create suitable, evidence-based treatment plans incorporating biologic therapies to manage moderate-to-severe asthma in affected patients
• Develop asthma management plans that include the selection of an optimal appropriate biologic therapy based on individual patient’s needs and preferences

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this enduring activity for a maximum of 0.75 ANCC contact hours.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this enduring activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
• Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
• Deborah Anderson, PhD, Medical Director for Med Learning Group, has nothing to disclose.
• M. Susan Burke, MD, has nothing to disclose.
• A medical reviewer from CME Peer Review LLC, has nothing to disclose.
• Abigail Dill, Program Manager for Med Learning Group, has nothing to disclose.
• Daniel DaSilva, Accreditation and Outcomes Coordinator, for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: October 30, 2025
EXPIRATION DATE: October 30, 2026

Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.